Pancreatic Adenocarcinoma Up-Regulated Factor Promotes Epithelial–Mesenchymal Transition and Lung Metastasis in Hepatocellular Carcinoma
International Journal of Molecular Sciences · 12.07.2026 · 27 (14) · 6213
DOI: 10.3390/ijms27146213 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.07.2026. Verfasst von Jeong-Ran Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Research Program, Scripps Korea Antibody Institute, Chuncheon-Si 24341, Gangwon-Do, Republic of Korea. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Liver Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scripps Korea Antibody Institute.
Abstract (Originalsprache)
Pancreatic adenocarcinoma upregulated factor (PAUF), a novel secreted protein highly expressed in pancreatic ductal adenocarcinoma, also influences cell invasiveness, motility, and proliferation in several cancer types. Transforming growth factor-beta (TGF-β)-induced PAUF expression enhances cancer cell migration and invasion in pancreatic ductal adenocarcinoma through mitogen-activated protein kinase (MEK)–extracellular signal-regulated kinase (ERK) activation; however, the roles of PAUF in regulating epithelial–mesenchymal transition (EMT) and promoting lung metastasis in hepatocellular carcinoma (HCC) remain unclear. Thus, we investigated the regulatory mechanisms and functional roles of TGF-β-induced PAUF expression in the HCC cell lines HepG2 and Huh-7, which showed high and low expression of intact TGF-β type I and II receptors, respectively. We found that TGF-β-induced PAUF expression is mediated through the activation of the TGF-β type I/II receptor–Smads signaling pathway and that PAUF promotes EMT-associated migration and invasion by stimulating the MEK–ERK signaling cascade. In vivo studies further demonstrated that PAUF plays a critical role in lung metastatic potential, as PAUF knockdown HepG2 cells exhibited markedly reduced pulmonary metastasis, whereas PAUF-overexpressing Huh-7 cells showed substantially enhanced lung metastasis. This study identifies PAUF as a critical promoter of lung metastatic potential in HCC cells and a potential therapeutic target for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Research Program, Scripps Korea Antibody Institute, Chuncheon-Si 24341, Gangwon-Do, Republic of Korea.
- Department of Biochemistry, School of Medicine, Wonkwang University, Iksan-Daero 460, Iksan-Si 54538, Jeonbuk-Do, Republic of Korea.
- Sarcopenia Total Solution Center, School of Medicine, Wonkwang University, Iksan-Daero 460, Iksan-Si 54538, Jeonbuk-Do, Republic of Korea.
- Institute of Wonkwang Medical Science, School of Medicine, Wonkwang University, Iksan-Daero 460, Iksan-Si 54538, Jeonbuk-Do, Republic of Korea.
ORCID-Profile: Jeong-Ran Park, Dong-Keon Lee
Förderung
- Scripps Korea Antibody Institute
Zitieren
APA
Park, J. R., Ham, H., Lee, M., Seo, J. H., & Lee, D. K. (2026). Pancreatic Adenocarcinoma Up-Regulated Factor Promotes Epithelial–Mesenchymal Transition and Lung Metastasis in Hepatocellular Carcinoma. International Journal of Molecular Sciences, 27(14), 6213. https://doi.org/10.3390/ijms27146213
Vancouver
Park JR, Ham H, Lee M, Seo JH, Lee DK. Pancreatic Adenocarcinoma Up-Regulated Factor Promotes Epithelial–Mesenchymal Transition and Lung Metastasis in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2026;27(14):6213. doi:10.3390/ijms27146213
BibTeX
@article{Park2026,
author = {Park, Jeong-Ran and Ham, Hyejun and Lee, Miso and Seo, Jae Ho and Lee, Dong-Keon},
title = {Pancreatic Adenocarcinoma Up-Regulated Factor Promotes Epithelial–Mesenchymal Transition and Lung Metastasis in Hepatocellular Carcinoma},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6213},
doi = {10.3390/ijms27146213}
}
EUVIMED